What’s going on here? They had a good start to the day then faded completely. Zero bounce from new states (including MA where they have a facility) implementing legalization. Meanwhile see MRMD which I considered overvalued up 20% today. Trying to be patient but hoping I haven’t bought the wrong horse. Let’s hope we get some good news on revenue soon. When will we get the next numbers? On the positive side I agree with earlier comments that press releases have been better. Would just like to hear some coherent comments fron leadership on when we can expect revenue to substantially increase. Even if they shared some info on deals with key customers that would be helpful. What I mean is who is going to use them for testing? So far it looks like nobody. Or even some numbers on samples tested or degree to which facilities are busy would be helpful. They really need to provide some tangible evidence of business progress to shareholders. All these acquisitions seem strategic but show me the $$$$$$! Sorry for the rant.